You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cell Biology

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumors, Pancreatic Neuroendocrine Tumor, Gastro-enteropancreatic Neuroendocrine Tumor Trial in Taiwan (CVM-1118)

Recruiting
  • Neuroendocrine Tumors
  • +4 more
  • Kaohsiung, Taiwan
  • +6 more
Aug 24, 2021

Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PD-1 inhibitor, Tenofovir Disoproxil)

Recruiting
  • Hepatitis B, Chronic
  • Vancouver, British Columbia, Canada
  • +31 more
Jan 17, 2023

Recurrence Monitoring in NSCLC Using Circulating Tumor DNA

Recruiting
  • Non Small Cell Lung Cancer
    • San Diego, California
      Scripps Health/Scripps Clinic Hillcrest/Scripps Clinic Torrey Pi
    Mar 21, 2021

    Sickle Cell Disease Trial in United States (SHP655, Placebo)

    Recruiting
    • Sickle Cell Disease
    • Birmingham, Alabama
    • +13 more
    Aug 16, 2021

    Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain, Recurrent Lung Small Cell Carcinoma Trial in

    Recruiting
    • Metastatic Lung Small Cell Carcinoma
    • +5 more
    • Memantine Hydrochloride
    • +3 more
    • Phoenix, Arizona
    • +83 more
    Apr 8, 2022

    Response to Gemcitabine Chemotherapy in Mycosis Fungoides

    Recruiting
    • Lymphoma, T-Cell, Cutaneous
    • Mycosis Fungoides
    • single-arm, non-randomized Biodynamic imaging (BDI)
    • Indianapolis, Indiana
      Indiana University School of Medicine, Department of Dermatology
    Nov 16, 2022

    Gastric Cancer Guided by Molecular Profiling

    Not yet recruiting
    • Gastric Cancer
      • (no location specified)
      Aug 4, 2020

      Melanoma, NSCLC, Brain Metastasis Trial in New Haven, Tampa (Pembrolizumab plus Bevacizumab)

      Recruiting
      • Melanoma
      • +2 more
      • Pembrolizumab plus Bevacizumab
      • New Haven, Connecticut
      • +1 more
      Feb 18, 2022

      Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal

      Recruiting
      • Prostate Cancer
      • +3 more
      • Stereotactic Body Radiotherapy
      • Edinburgh, Mid Lothian, United Kingdom
        Edinburgh Cancer Centre, Western General Hospital
      Apr 5, 2022

      COVID-19 Trial in Kunming (ZR-202-CoV, Placebo)

      Recruiting
      • COVID-19
      • ZR-202-CoV
      • Placebo
      • Kunming, Yunan, China
        Clinical Trial Institution for Anning First Hospital
      Apr 5, 2022

      Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in United States

      Completed
      Has Results
      • Recurrent Fallopian Tube Carcinoma
      • +2 more
      • Bevacizumab
      • +3 more
      • Phoenix, Arizona
      • +44 more
      Jan 10, 2022

      NSCLC, Triple Negative Breast Cancer Trial in China (Datopotamab Deruxtecan (Dato-DXd))

      Recruiting
      • Carcinoma, Non-Small-Cell Lung
      • Triple Negative Breast Cancer
      • Datopotamab Deruxtecan (Dato-DXd)
      • Beijing, China
      • +27 more
      Aug 11, 2022

      Mature B-Cell Malignancies Trial in Worldwide (BGB-11417, Zanubrutinib)

      Recruiting
      • Mature B-Cell Malignancies
      • Stanford, California
      • +26 more
      Dec 16, 2021

      Xerostomia Trial in Stanford (drug, radiation, other)

      Recruiting
      • Xerostomia
      • D-Limonene Gelcaps
      • +3 more
      • Stanford, California
        Stanford University
      Mar 11, 2022

      NSCLC Trial in China, Taiwan (Encorafenib, Binimetinib)

      Recruiting
      • Non-Small Cell Lung Cancer
      • Beijing, China
      • +35 more
      Jun 29, 2022

      COVID-19 Infection, COVID-19 VACCINE Trial in Thailand (AstraZeneca ChAdOx1 AZD1222 vaccine (AZ) full dose, Pfizer/BioNTech

      Completed
      • COVID-19 Infection
      • COVID-19 VACCINE
      • AstraZeneca ChAdOx1 AZD1222 vaccine (AZ) full dose
      • +3 more
      • Bangkok Noi, Bangkok, Thailand
      • +6 more
      Jul 3, 2022

      Metastatic Triple-negative Breast Cancer Trial in Italy (Tissue Immune Profile)

      Recruiting
      • Metastatic Triple-negative Breast Cancer
      • Tissue Immune Profile
      • Prato, FI, Italy
      • +6 more
      Apr 14, 2023

      Urinary Incontinence, Stress, Urination Disorders Trial in United States (autologous muscle-derived cells (AMDC))

      Completed
      Has Results
      • Urinary Incontinence
      • +5 more
      • autologous muscle-derived cells (AMDC)
      • Miami, Florida
      • +4 more
      Oct 28, 2021

      Hematological Tumors, Recurrence Trial in Shanghai (Peg interferon alfa-2b)

      Recruiting
      • Hematological Neoplasms
      • Recurrence
      • Peg interferon alfa-2b
      • Shanghai, Shanghai, China
        Shanghai Jiao Tong University Affilated First People's Hospital
      Oct 10, 2021

      Diabetic Neuropathic Pain, Healthy Volunteers Trial in Fukuoka (BAY2395840)

      Recruiting
      • Diabetic Neuropathic Pain
      • Healthy Volunteers
      • Fukuoka, Japan
        SOUSEIKAI Fukuoka Mirai Hospital
      Jan 10, 2023

      Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric

      Active, not recruiting
      • Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
      • +3 more
      • Phoenix, Arizona
      • +219 more
      Aug 16, 2022

      Fallopian Tube Mucinous Adenocarcinoma, Ovarian Seromucinous Carcinoma, Platinum-Refractory Fallopian Tube Carcinoma Trial in

      Recruiting
      • Fallopian Tube Mucinous Adenocarcinoma
      • +49 more
      • Cediranib Maleate
      • +5 more
      • Anchorage, Alaska
      • +373 more
      Aug 17, 2022

      Kidney Cancer Trial in United States (Gemcitabine, Sunitinib)

      Completed
      Has Results
      • Kidney Cancer
      • Birmingham, Alabama
      • +98 more
      Dec 29, 2021

      Acute Myeloid Leukemia Trial in Suzhou (anti-CLL1 CART)

      Recruiting
      • Acute Myeloid Leukemia
      • anti-CLL1 CART
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      May 10, 2021

      Acute Lymphoblastic Leukemia, Pediatric Trial in Canada, United States (Pegaspargase, Erwinia asparaginase, Cyclophosphamide)

      Active, not recruiting
      • Acute Lymphoblastic Leukemia, Pediatric
      • Boston, Massachusetts
      • +8 more
      Nov 10, 2022